Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000238

NIDA-06969-20

R01-06969-20

Details and patient eligibility

About

The purpose of this study is to assess the degree in which opioid-dependent outpatients discount the value of an additional maintenance dose of buprenorphine under differing states of opioid deprivation.

Sex: All

Ages: 18 to 47 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.